Journal of Clinical Endocrinology & Metabolism, Vol 80, 468-472, Copyright © 1995 by Endocrine Society

ARTICLES

Assay of thyroglobulin in serum with thyroglobulin autoantibodies: an unobtainable goal?

S Mariotti, G Barbesino, P Caturegli, M Marino, L Manetti, F Pacini, R Centoni and A Pinchera
Institute of Endocrinology, University of Pisa, Italy.

Measurement of thyroglobulin (Tg) in serum with anti-Tg autoantibodies (TgAb) represents a difficult challenge. Immunoradiometric assays (IRMA) employing monoclonal anti-Tg antibodies not cross-reacting with endogenous TgAb have recently been developed and proposed for Tg assays in TgAb-positive sera. The aim of the present investigation was to assess the clinical reliability of this approach. Assays of serum Tg in patients with and without TgAb using one such monoclonal antibody IRMA (Thyroglobulin IRMA-Pasteur; IRMA-1) were compared with those obtained by a conventional IRMA employing polyclonal anti-Tg antibodies (HTGK- Sorin; IRMA-2). Preliminary studies for assessment of the interference of TgAb showed that the recovery of added Tg was significantly higher (P < 0.01) when determined by IRMA-1 (64.6 +/- 23%) than by IRMA-2 (49.5 +/- 20%). Study groups included 79 patients with differentiated thyroid carcinoma (DTC) treated by total thyroidectomy and radioiodine ablation; 24 had no metastases or residual thyroid tissue, 31 had a thyroid residue, and 24 had metastatic disease. Seventy-five patients with autoimmune thyroid disease (47 with Graves' and 28 with Hashimoto's disease) were also included. In TgAb-negative sera from DTC patients, similar Tg concentrations were found by both IRMA, i.e. undetectable in most patients with no residual thyroid or neoplastic tissue, low to moderately elevated in the majority of those with residual thyroid tissue, and markedly elevated in all patients with metastatic disease. Serum Tg was undetectable by both assays in several TgAb-positive sera from DTC patients with residual thyroid tissue or metastatic disease, respectively, in whom a detectable or even high serum Tg concentration was expected. Despite the lower in vitro interference of TgAb in IRMA-1, there was no difference between the two assays. In the group of patients with thyroid autoimmune disease, serum Tg concentrations were found to be high in TgAb-negative sera and much lower in TgAb-positive sera by both IRMAs. In conclusion, the present study demonstrates that the use of a monoclonal antibody IRMA for serum Tg, although less susceptible to in vitro TgAb interference, does not necessarily provide any substantial advantage with respect to a conventional polyclonal IRMA in detecting Tg in TgAb-positive sera. The finding of undetectable or lower than expected serum Tg by either method in TgAb-positive serum may well reflect a truly reduced serum Tg concentration. This might be due to an accelerated Tg metabolic clearance in the presence of TgAb.(ABSTRACT TRUNCATED AT 400 WORDS)

This article has been cited by other articles:

				R. B T Verkooijen, F. A Verburg, J. W van Isselt, C. J M Lips, J. W Smit, and M. P M Stokkel The success rate of I-131 ablation in differentiated thyroid cancer: comparison of uptake-related and fixed-dose strategies Eur. J. Endocrinol., September 1, 2008; 159(3): 301 - 307. [Abstract] [Full Text] [PDF]

				F. Latrofa, D. Ricci, L. Grasso, P. Vitti, L. Masserini, F. Basolo, C. Ugolini, G. Mascia, A. Lucacchini, and A. Pinchera Characterization of Thyroglobulin Epitopes in Patients with Autoimmune and Non-Autoimmune Thyroid Diseases Using Recombinant Human Monoclonal Thyroglobulin Autoantibodies J. Clin. Endocrinol. Metab., February 1, 2008; 93(2): 591 - 596. [Abstract] [Full Text] [PDF]

				M. Schlumberger, A. Hitzel, M. E. Toubert, C. Corone, F. Troalen, M. H. Schlageter, F. Claustrat, S. Koscielny, D. Taieb, M. Toubeau, et al. Comparison of Seven Serum Thyroglobulin Assays in the Follow-Up of Papillary and Follicular Thyroid Cancer Patients J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2487 - 2495. [Abstract] [Full Text] [PDF]

				A. C.M. Persoon, T. P. Links, J. Wilde, W. J. Sluiter, B. H.R. Wolffenbuttel, and J. M.W. van den Ouweland Thyroglobulin (Tg) Recovery Testing with Quantitative Tg Antibody Measurement for Determining Interference in Serum Tg Assays in Differentiated Thyroid Carcinoma Clin. Chem., June 1, 2006; 52(6): 1196 - 1199. [Abstract] [Full Text] [PDF]

				F. Boi, G. Baghino, F. Atzeni, M. L. Lai, G. Faa, and S. Mariotti The Diagnostic Value for Differentiated Thyroid Carcinoma Metastases of Thyroglobulin (Tg) Measurement in Washout Fluid from Fine-Needle Aspiration Biopsy of Neck Lymph Nodes Is Maintained in the Presence of Circulating Anti-Tg Antibodies J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1364 - 1369. [Abstract] [Full Text] [PDF]

				J. R. Stockigt Ambiguous Thyroglobulin Assay Results in the Follow-Up of Differentiated Thyroid Carcinoma J. Clin. Endocrinol. Metab., October 1, 2005; 90(10): 5904 - 5905. [Full Text] [PDF]

				C. A. Spencer, L. M. Bergoglio, M. Kazarosyan, S. Fatemi, and J. S. LoPresti Clinical Impact of Thyroglobulin (Tg) and Tg Autoantibody Method Differences on the Management of Patients with Differentiated Thyroid Carcinomas J. Clin. Endocrinol. Metab., October 1, 2005; 90(10): 5566 - 5575. [Abstract] [Full Text] [PDF]

				R Gorges, M Maniecki, W Jentzen, S. n-Y. Sheu, K Mann, A Bockisch, and O E Janssen Development and clinical impact of thyroglobulin antibodies in patients with differentiated thyroid carcinoma during the first 3 years after thyroidectomy Eur. J. Endocrinol., July 1, 2005; 153(1): 49 - 55. [Abstract] [Full Text] [PDF]

				O. E. Okosieme, C. Evans, L. Moss, A. B. Parkes, L.D. K. E. Premawardhana, and J. H. Lazarus Thyroglobulin Antibodies in Serum of Patients with Differentiated Thyroid Cancer: Relationship between Epitope Specificities and Thyroglobulin Recovery Clin. Chem., April 1, 2005; 51(4): 729 - 734. [Abstract] [Full Text] [PDF]

				F. A Verburg, B. de Keizer, C. J M Lips, P. M J Zelissen, and J. M H de Klerk Prognostic significance of successful ablation with radioiodine of differentiated thyroid cancer patients Eur. J. Endocrinol., January 1, 2005; 152(1): 33 - 37. [Abstract] [Full Text] [PDF]

				C. A. Spencer Challenges of Serum Thyroglobulin (Tg) Measurement in the Presence of Tg Autoantibodies J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 3702 - 3704. [Full Text] [PDF]

				E. L. Mazzaferri, R. J. Robbins, C. A. Spencer, L. E. Braverman, F. Pacini, L. Wartofsky, B. R. Haugen, S. I. Sherman, D. S. Cooper, G. D. Braunstein, et al. A Consensus Report of the Role of Serum Thyroglobulin as a Monitoring Method for Low-Risk Patients with Papillary Thyroid Carcinoma J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1433 - 1441. [Abstract] [Full Text] [PDF]

				N. G. Morgenthaler, J. Froehlich, J. Rendl, M. Willnich, C. Alonso, A. Bergmann, and C. Reiners Technical Evaluation of a New Immunoradiometric and a New Immunoluminometric Assay for Thyroglobulin Clin. Chem., July 1, 2002; 48(7): 1077 - 1083. [Abstract] [Full Text] [PDF]

				C. Massart and D. Maugendre Importance of the Detection Method for Thyroglobulin Antibodies for the Validity of Thyroglobulin Measurements in Sera from Patients with Graves Disease Clin. Chem., January 1, 2002; 48(1): 102 - 107. [Abstract] [Full Text] [PDF]

				S. B. Nøhr and P. Laurberg Opposite Variations in Maternal and Neonatal Thyroid Function Induced by Iodine Supplementation during Pregnancy J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 623 - 627. [Abstract] [Full Text]

				M. D. Ringel, P. L. Balducci-Silano, J. S. Anderson, C. A. Spencer, J. Silverman, Y. H. Sparling, G. L. Francis, K. D. Burman, L. Wartofsky, P. W. Ladenson, et al. Quantitative Reverse Transcription-Polymerase Chain Reaction of Circulating Thyroglobulin Messenger Ribonucleic Acid for Monitoring Patients with Thyroid Carcinoma J. Clin. Endocrinol. Metab., November 1, 1999; 84(11): 4037 - 4042. [Abstract] [Full Text]

				C. A. Spencer, M. Takeuchi, M. Kazarosyan, C. C. Wang, R. B. Guttler, P. A. Singer, S. Fatemi, J. S. LoPresti, and J. T. Nicoloff Serum Thyroglobulin Autoantibodies: Prevalence, Influence on Serum Thyroglobulin Measurement, and Prognostic Significance in Patients with Differentiated Thyroid Carcinoma J. Clin. Endocrinol. Metab., April 1, 1998; 83(4): 1121 - 1127. [Abstract] [Full Text]

				P. Laurberg, K. M. Pedersen, A. Hreidarsson, N. Sigfusson, E. Iversen, and P. R. Knudsen Iodine Intake and the Pattern of Thyroid Disorders: A Comparative Epidemiological Study of Thyroid Abnormalities in the Elderly in Iceland and in Jutland, Denmark J. Clin. Endocrinol. Metab., March 1, 1998; 83(3): 765 - 769. [Abstract] [Full Text]

				M. J. Schlumberger Papillary and Follicular Thyroid Carcinoma N. Engl. J. Med., January 29, 1998; 338(5): 297 - 306. [Full Text] [PDF]

				C. Calzolari, P.-Y. Marquet, B. Pau, C. A. Spencer, and M. Takeuchi Thyroglobulin IRMA Pasteur Immunoassay: Sensitivity of the Assay and Interference from Thyroglobulin Autoantibodies • The authors of the above-mentioned article and editorial reply: Clin. Chem., February 1, 1997; 43(2): 413 - 415. [Full Text]